无创正压通气治疗COPD并呼吸衰竭的临床疗效

The Clinical Efficacy of Noninvasive Positive Pressure Ventilation in the Treatment of COPD and Respiratory Failure

目的探究无创正压通气治疗COPD并呼吸衰竭的临床疗效。方法选择2013年1月~2014年12月收治的106例COPD并呼吸衰竭患者,将其随机分为对照组和治疗组,对照组54例给予常规治疗,治疗组52例给予无创正压通气治疗,比较两组治疗效果。结果两组治疗后Pa O2、Pa CO2、呼吸次数及心率情况与治疗前对比均有明显变化,且差异具有统计学意义,P〈0.05;治疗组住院天数、插管率较少,与对照组比较差异具有统计学意义P〈0.05。结论对于COPD并呼吸衰竭的患者,使用无创正压通气治疗,疗效较佳。

Objective To explore the clinical efficacy of noninvasive positive pressure ventilation in the treatment of COPD and respiratory failure. Methods Selected 106 patients with COPD and respiratory failure from January 2013 to December 2014 and randomly divided into control group and the treatment group, 54 patients in control group received conventional treatment, 52 patients in treatment group received noninvasive positive pressure ventilation therapy, treatment effects were compared. Results After treatment, Pa O2, Pa CO2, heart rate, respiratory rate and comparison with the situation prior to treatment changed significantly, and the inter-group differences were significant, P〈0.05, in treatment group, length of stay, fewer intubation rate, compared with the control group, P〈0.05. Conclusion For patients with COPD and respiratory failure, the use of noninvasive positive pressure ventilation therapy can get better efficacy.